Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NorthWest Healthcare Properties Real Estate Invest 10 Convert Sub Debentures 31 March 2025 T.NWH.DB.G

Alternate Symbol(s):  T.NWH.DB.H | T.NWH.DB.I | T.NWH.UN | NWHUF

Northwest Healthcare Properties Real Estate Investment Trust is an open-ended real estate investment trust. The Company is the owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia. The principal business of the Company is to invest in healthcare real estate globally. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings; and life sciences, research, and education. It provides investors with access to a portfolio of international healthcare real estate infrastructure of interests in a diversified portfolio of about 196 income-producing properties located throughout major markets in North America, Brazil, Europe and Australasia. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies.


TSX:NWH.DB.G - Post by User

Post by Zipolitemexicoon Sep 02, 2024 12:50pm
621 Views
Post# 36205243

Scotia Research (August 15, 2024):

Scotia Research (August 15, 2024):Latest Research (August 15, 2024):OUR TAKE: Mixed. NWH unit price was down ~5% yesterday as market focus was on Q2 miss (details on page 7), while UK portfolio sale was completely overlooked. We think UKportfolio sale has materially improved the risk profile, and as such we expect valuation discount to narrow.
NWH is now trading at 30% discount to NAV (Exhibit 4) and 8.1% implied cap rate (Exhibit 9). Our 12-month targetis $6.50, which is largely based on our NAVPU of $6.75 (unchanged) and implies 9.7x 2025E AFFO multiple.NWHdistribution yield is 7.6% and implies AFFO payout ratio (Exhibit 2) of 90% in 2024 and 74% in 2025. So, we thinkdistribution is fully covered. Leverage (Exhibit 5) reduction at 55% vs 61% in Q2 and 59% last year. Leverage iselevated but has come down on $1.6B of asset dispositions in the last one year. 2025 debt maturities have reduced to 27% (as % of total debt) vs 42% previously. We maintain our SP rating as we see FFOPU y/y growth (beginning from Q1/25 and still y/y declines in Q3/24 and Q4/24. We see $5 as the new floor,and the stock could move towards $6 as 2025 earnings growth is visible

<< Previous
Bullboard Posts
Next >>